The introduction of extracorporeal circulation by John H. Gibbon in 1953 heralded the era of modern cardiac surgery. Continuous improvements in perfusion technology will also guarantee the development of cardiac surgery therapy options in the future.

Medos concentrates on continuous development of innovative therapy solutions for cardiac surgeons and perfusionists. Whether aortic valve replacement or bypass surgery, almost all cardiac surgery procedures can be performed effectively using Medos products.